Optimal Time Point of Response Assessment for Predicting Survival is Associated with Tumor Burden in Hepatocellular Carcinoma Receiving Repeated Transarterial Chemoembolization Dongdong Xia , Qiuhe Wang , Wei Bai , Enxin Wang , Zhexuan Wang , Wei Mu , Junhui Sun , Ming Huang , Guowen Yin , Hailiang Li , Hui Zhao , Chunqing Zhang , Jing Li , Jianbing Wu , Xiaoli Zhu , Shufa Yang , Xingnan Pan , Jiaping Li , Zixiang Li , Guohui Xu , Haibin Shi , Hui Zhang , Yuelin Zhang , Rong Ding , Hui Yu , Lin Zheng , Xiaohu Yang , Guangchuan Wang , Nan You , Long Feng , Shuai Zhang , Wukui Huang , Tao Xu , Wenzhe Fan , Xueda Li , Xuegang Yang , Weizhong Zhou , Wenjun Wang , Xiaomei Li , Zhengyu Wang , Bohan Luo , Jing Niu , Jie Yuan , Yong Lv , Kai Li , Wengang Guo , Zhanxin Yin , Daiming Fan , Jielai Xia , Guohong Han European Radiology（2022）
Key words
Chemoembolization, Tumor burden, Carcinoma, hepatocellular, Surrogate endpoint
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
